A foveal-sparing pattern of cytomegalovirus retinitis in the acquired immunodeficiency syndrome
- PMID: 8743006
- DOI: 10.1111/j.1442-9071.1996.tb01552.x
A foveal-sparing pattern of cytomegalovirus retinitis in the acquired immunodeficiency syndrome
Abstract
Purpose: We describe the clinical course of 12 eyes of 10 patients in whom recurrent cytomegalovirus (CMV) retinitis exhibited a foveal-sparing pattern.
Methods: We retrospectively reviewed the case records and photographic charts of 10 patients (12 eyes) with the acquired immunodeficiency syndrome (AIDS), in whom recurrent CMV retinitis exhibited a foveal-sparing pattern within 1500 mm of the foveola.
Results: The site of primary retinitis was temporal in 10 eyes of nine patients in whom it was known. The median number of recurrences up to the observation of foveal-sparing retinitis was two (range one to eight), and five patients had active CMV retinitis despite treatment for at least two continuous months. Once established, the median rate of progression in a non-foveal vector was 2.3 times faster than toward the fovea, and the median time to reduction in acuity to < 6/30 (or death) was 11 to 14 weeks. Three eyes of three patients retained 6/30 or better acuity up to death. Foveal CMV retinitis ultimately reduced acuity to < 6/30 in five eyes. Six eyes suffered retinal detachment, involving the fovea in five, and being the primary reason for acuity of < 6/30 in four. Four patients suffered dose-limiting toxicity.
Conclusion: Foveal-sparing CMV retinitis arises in patients with recurrent CMV retinitis resistant to treatment ('clinically resistant'), particularly that which has arisen temporally. Despite its foveolar proximity, and ultimate significant loss of function, the pattern of progression allows for preservation of useful foveal vision for longer periods than would have been expected.
Similar articles
-
Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.Arch Ophthalmol. 1996 Jan;114(1):23-33. doi: 10.1001/archopht.1996.01100130021004. Arch Ophthalmol. 1996. PMID: 8540847 Clinical Trial.
-
Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.Ophthalmology. 1995 Dec;102(12):1865-70. doi: 10.1016/s0161-6420(95)30782-8. Ophthalmology. 1995. PMID: 9098289
-
Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis.Arch Ophthalmol. 1996 Jul;114(7):815-20. doi: 10.1001/archopht.1996.01100140029003. Arch Ophthalmol. 1996. PMID: 8660164
-
Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.Infect Agents Dis. 1995 Sep;4(3):131-42. Infect Agents Dis. 1995. PMID: 8548191 Review.
-
Cytomegalovirus retinitis: diagnosis and status of systemic therapy.J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14 Suppl 1:S1-6. doi: 10.1097/00042560-199700001-00002. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9058611 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical